uniQure (QURE) Net Equity Issued and Repurchased (2016 - 2021)
uniQure (QURE) posted quarterly Net Equity Issued and Repurchased of $2.2 million for Q2 2021, down 14.73% year-over-year from $2.5 million in Q2 2020, and down 92.47% quarter-over-quarter from $28.7 million in Q1 2021.
Analysis
uniQure (QURE) Net Equity Issued and Repurchased (2016 - 2021) Analysis & Trends
uniQure's Net Equity Issued and Repurchased history runs 6 years deep, the most recent figure standing at $2.2 million for Q2 2021.
- In Q2 2021, Net Equity Issued and Repurchased fell 14.73% year-over-year to $2.2 million; the TTM figure through Dec 2021 stood at $30.9 million (up 315.09% YoY), while the FY2021 annual figure was $30.9 million, up 315.09% from the prior year.
- Net Equity Issued and Repurchased for Q2 2021 stood at $2.2 million, down from $28.7 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $28.7 million in Q1 2021, with the low at $97000.0 in Q3 2017.
- The 5-year median for Net Equity Issued and Repurchased is $1.5 million (2018), against an average of $2.9 million.
- The sharpest annual moves came in 2018 and 2021: Net Equity Issued and Repurchased slumped 93.75% in 2018, then jumped 2744.95% in 2021.
- uniQure's Net Equity Issued and Repurchased stood at $3.0 million in 2017, then plunged by 93.75% to $188000.0 in 2018, then soared by 753.72% to $1.6 million in 2019, then jumped by 134.02% to $3.8 million in 2020, then plunged by 42.36% to $2.2 million in 2021.
- Business Quant data shows QURE's Net Equity Issued and Repurchased at $2.2 million in Q2 2021, $28.7 million in Q1 2021, and $3.8 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 2.17 Mn |
| Mar 31, 2021 | 28.73 Mn |
| Dec 31, 2020 | 3.76 Mn |
| Sep 30, 2020 | 139,000.00 |
| Jun 30, 2020 | 2.54 Mn |
| Mar 31, 2020 | 1.01 Mn |
| Dec 31, 2019 | 1.61 Mn |
| Sep 30, 2019 | 1.28 Mn |
| Jun 30, 2019 | 543,000.00 |
| Mar 31, 2019 | 2.18 Mn |
| Dec 31, 2018 | 188,000.00 |
| Sep 30, 2018 | 1.65 Mn |
| Jun 30, 2018 | 1.43 Mn |
| Mar 31, 2018 | 1.56 Mn |
| Dec 31, 2017 | 3.01 Mn |
| Sep 30, 2017 | 97,000.00 |
| Jun 30, 2017 | 498,000.00 |
| Mar 31, 2017 | 441,000.00 |
| Dec 31, 2016 | 375,000.00 |
| Sep 30, 2016 | 23,000.00 |